Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-011437

SVP & Chief Commercial Officer sold 4,852 shares at $10.95 ($53,129)

From the SEC's structured data for this filing

Trades in this filing

NORTHCOTT JOHN · SVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-16 Sale : show line 1 in the form −4,852 $10.95 $53,129 227,802 D
Open-market sales · 4,852 sh · avg $10.95 · $53,129
Loading xslF345X03/doc4.xml…